Literature DB >> 23830827

Thermoreversible hyaluronan-based hydrogel supports in vitro and ex vivo disc-like differentiation of human mesenchymal stem cells.

Marianna Peroglio1, David Eglin, Lorin M Benneker, Mauro Alini, Sibylle Grad.   

Abstract

BACKGROUND CONTEXT: The fate of human mesenchymal stem cells (hMSCs) supplied to the degenerating intervertebral disc (IVD) is still not fully understood and can be negatively affected by low oxygen, pH, and glucose concentration of the IVD environment. The hMSC survival and yield upon injection of compromised IVD could be improved by the use of an appropriate carrier and/or by predifferentiation of hMSCs before injection.
PURPOSE: To optimize hMSC culture conditions in thermoreversible hyaluronan-based hydrogel, hyaluronan-poly(N-isopropylacrylamide) (HA-pNIPAM), to achieve differentiation toward the disc phenotype in vitro, and evaluate whether preconditioning contributes to a better hMSC response ex vivo. STUDY
DESIGN: In vitro and ex vivo whole-organ culture of hMSCs.
METHODS: In vitro cultures of hMSCs were conducted in HA-pNIPAM and alginate for 1 week under hypoxia in chondropermissive medium alone and with the supplementation of transforming growth factor β1 or growth and differentiation factor 5 (GDF-5). Ex vivo, hMSCs were either suspended in HA-pNIPAM and directly supplied to the IVDs or predifferentiated with GDF-5 for 1 week in HA-pNIPAM and then supplied to the IVDs. Cell viability was evaluated by Live-Dead assay, and DNA, glycosaminoglycan (GAG), and gene expression profiles were used to assess hMSC differentiation toward the disc phenotype.
RESULTS: The HA-pNIPAM induced hMSC differentiation toward the disc phenotype more effectively than alginate: in vitro, higher GAG/DNA ratio and higher collagen type II, SOX9, cytokeratin-19, cluster of differentiation 24, and forkhead box protein F1 expressions were found for hMSCs cultured in HA-pNIPAM compared with those cultured in alginate, regardless of the addition of growth factors. Ex vivo, direct combination of HA-pNIPAM with the disc environment induced a stronger disc-like differentiation of hMSCs than predifferentiation of hMSCs followed by their delivery to the discs.
CONCLUSIONS: Hyaluronan-based thermoreversible hydrogel supports hMSC differentiation toward the disc phenotype without the need for growth factor supplementation in vitro and ex vivo. Further in vivo studies are required to confirm the suitability of this hydrogel as an effective stem cell carrier for the treatment of IVD degeneration.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Human mesenchymal stem cells; Hyaluronan; Intervertebral disc; Thermoreversible hydrogel; Whole-organ culture

Mesh:

Substances:

Year:  2013        PMID: 23830827     DOI: 10.1016/j.spinee.2013.05.029

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  28 in total

1.  Screening of hyaluronic acid-poly(ethylene glycol) composite hydrogels to support intervertebral disc cell biosynthesis using artificial neural network analysis.

Authors:  Claire G Jeong; Aubrey T Francisco; Zhenbin Niu; Robert L Mancino; Stephen L Craig; Lori A Setton
Journal:  Acta Biomater       Date:  2014-05-21       Impact factor: 8.947

2.  Development of an ex vivo cavity model to study repair strategies in loaded intervertebral discs.

Authors:  Zhen Li; Patrick Lezuo; Girish Pattappa; Estelle Collin; Mauro Alini; Sibylle Grad; Marianna Peroglio
Journal:  Eur Spine J       Date:  2016-04-01       Impact factor: 3.134

Review 3.  Stem cells sources for intervertebral disc regeneration.

Authors:  Gianluca Vadalà; Fabrizio Russo; Luca Ambrosio; Mattia Loppini; Vincenzo Denaro
Journal:  World J Stem Cells       Date:  2016-05-26       Impact factor: 5.326

4.  In vitro characterization of a stem-cell-seeded triple-interpenetrating-network hydrogel for functional regeneration of the nucleus pulposus.

Authors:  Lachlan J Smith; Deborah J Gorth; Brent L Showalter; Joseph A Chiaro; Elizabeth E Beattie; Dawn M Elliott; Robert L Mauck; Weiliam Chen; Neil R Malhotra
Journal:  Tissue Eng Part A       Date:  2014-03-21       Impact factor: 3.845

5.  Poly(γ-glutamic acid) and poly(γ-glutamic acid)-based nanocomplexes enhance type II collagen production in intervertebral disc.

Authors:  Joana C Antunes; Catarina Leite Pereira; Graciosa Q Teixeira; Ricardo V Silva; Joana Caldeira; Sibylle Grad; Raquel M Gonçalves; Mário A Barbosa
Journal:  J Mater Sci Mater Med       Date:  2016-11-24       Impact factor: 3.896

6.  * Thermosensitive Poly(N-vinylcaprolactam) Injectable Hydrogels for Cartilage Tissue Engineering.

Authors:  Renata L Sala; Mi Y Kwon; Minwook Kim; Sarah E Gullbrand; Elizabeth A Henning; Robert L Mauck; Emerson R Camargo; Jason A Burdick
Journal:  Tissue Eng Part A       Date:  2017-04-06       Impact factor: 3.845

7.  Synthesis of Thermogelling Poly(N-isopropylacrylamide)-graft-chondroitin Sulfate Composites with Alginate Microparticles for Tissue Engineering.

Authors:  Thomas R Christiani; Katelynn Toomer; Joseph Sheehan; Angelika Nitzl; Amanda Branda; Elizabeth England; Pamela Graney; Cristina Iftode; Andrea J Vernengo
Journal:  J Vis Exp       Date:  2016-10-26       Impact factor: 1.355

8.  Photocrosslinkable laminin-functionalized polyethylene glycol hydrogel for intervertebral disc regeneration.

Authors:  Aubrey T Francisco; Priscilla Y Hwang; Claire G Jeong; Liufang Jing; Jun Chen; Lori A Setton
Journal:  Acta Biomater       Date:  2013-11-25       Impact factor: 8.947

Review 9.  Organ culture bioreactors--platforms to study human intervertebral disc degeneration and regenerative therapy.

Authors:  Benjamin Gantenbein; Svenja Illien-Jünger; Samantha C W Chan; Jochen Walser; Lisbet Haglund; Stephen J Ferguson; James C Iatridis; Sibylle Grad
Journal:  Curr Stem Cell Res Ther       Date:  2015       Impact factor: 3.828

Review 10.  Stem cell regeneration of degenerated intervertebral discs: current status (update).

Authors:  Hamish T J Gilbert; Judith A Hoyland; Stephen M Richardson
Journal:  Curr Pain Headache Rep       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.